What is the appropriate management of acute kidney injury in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Kidney Injury in Pregnancy

Pregnant women with AKI require immediate multidisciplinary management focused on identifying and treating the underlying cause, maintaining hemodynamic stability with safe antihypertensive agents, and timely delivery when indicated, while avoiding nephrotoxic medications and ACE inhibitors/ARBs which are absolutely contraindicated.

Immediate Assessment and Risk Stratification

When AKI is suspected in pregnancy, rapidly assess:

  • Gestational age and trimester-specific causes
  • Blood pressure - severe hypertension (≥160/110 mmHg) requires urgent treatment 1
  • Proteinuria and laboratory markers - hemoglobin, platelets, liver enzymes, uric acid, creatinine 1
  • Volume status - distinguish prerenal from intrinsic causes
  • Fetal well-being - continuous monitoring in severe cases

Trimester-Specific Etiologies

First trimester: Hyperemesis gravidarum is the most common cause 2, 3

Second/Third trimester: Hypertensive disorders (preeclampsia, HELLP syndrome), acute fatty liver of pregnancy, thrombotic microangiopathies (TTP, HUS), placental abruption, and sepsis 4, 2, 3, 5

Blood Pressure Management

For severe hypertension (≥160/110 mmHg):

  • Requires urgent treatment in a monitored setting 1
  • Safe agents: oral nifedipine, IV labetalol, or IV hydralazine 6, 1
  • Target BP: 110-140/85 mmHg or diastolic ≤85 mmHg 1, 7

For chronic hypertension with renal disease:

  • Methyldopa remains first-line with best long-term safety data 6, 8
  • Labetalol increasingly preferred due to fewer side effects 8
  • Beta-blockers generally safe (avoid atenolol due to growth restriction risk) 6, 8
  • Nifedipine acceptable but avoid sublingual/rapid IV administration 6

Absolutely contraindicated: ACE inhibitors and ARBs cause fetal renal dysgenesis and death 6, 9, 8

Fluid and Hemodynamic Management

  • Volume resuscitation with crystalloids for prerenal causes
  • Avoid overaggressive fluid administration - can worsen outcomes in some conditions 10
  • Diuretics: Use loop diuretics (furosemide) only for volume overload in renal/cardiac failure 6
  • Thiazides contraindicated in preeclampsia as they reduce uteroplacental perfusion 6
  • Vasopressors with fluids if vasomotor shock present 10

Cause-Specific Treatment

Preeclampsia/HELLP syndrome:

  • Magnesium sulfate for seizure prophylaxis (4g IV or 10g IM loading, then 5g IM q4h or 1g/h infusion) 1
  • Definitive treatment is delivery 6
  • Steroids for fetal lung maturation if <34 weeks 6

Acute fatty liver of pregnancy: Prompt delivery 2, 3

Thrombotic microangiopathies:

  • TTP: Plasmapheresis 2, 3
  • Atypical HUS: Eculizumab 2, 3

Glomerulonephritis: Steroids and immunosuppressive therapy 2, 3

Renal Replacement Therapy

Indications for dialysis:

  • Standard criteria apply (severe acidosis, hyperkalemia, uremia, volume overload)
  • Early, aggressive dialysis (≈36 hours/week) provides best outcomes in progressive renal disease 1
  • Both hemodialysis and peritoneal dialysis are options 11
  • Maternal survival excellent with RRT; fetal survival 74% with HD, 40% with PD 11

Monitoring Requirements

Maternal monitoring:

  • Serial creatinine and urine output
  • Blood pressure (preferably weekly home monitoring) 1, 7
  • Monthly urinalysis; treat asymptomatic bacteriuria 7
  • Laboratory tests at minimum 28 and 34 weeks 1

Fetal monitoring:

  • Ultrasound for growth from 26 weeks, every 2-4 weeks 1
  • More frequent if growth restriction suspected
  • Soluble fms-like tyrosine kinase-1 to placental growth factor ratio from 24 weeks if available 7

Timing of Delivery

  • Preeclampsia with worsening maternal condition or fetal distress: Immediate delivery 6
  • Gestational hypertension without preeclampsia: Can delay until 39+6 weeks if controlled 1
  • Severe AKI with maternal instability: Delivery often necessary regardless of gestational age

Critical Pitfalls to Avoid

  1. Never use ACE inhibitors or ARBs - even inadvertent first-trimester exposure requires close monitoring and immediate discontinuation 6, 9, 8
  2. Do not restrict salt in preeclampsia - may worsen intravascular volume 9
  3. Avoid sublingual/rapid IV nifedipine - can cause MI or fetal distress 6
  4. Do not delay delivery in severe preeclampsia hoping for medical management 6
  5. Stop tolvaptan and other teratogenic drugs before pregnancy 7

Postpartum Management

  • Restart heparin 6-12 hours after delivery if recent VTE 9
  • Warfarin safe for breastfeeding (start day 2 postpartum) 9
  • Continue monitoring renal function - some AKI persists long-term 12, 4
  • Women with moderate-severe renal insufficiency (creatinine ≥3 mg/dL) may have permanent worsening in 40% of cases 12, 8

Long-term Considerations

Pregnant women with pre-existing renal disease face worse maternal and fetal outcomes even with mild CKD 1. Those with progressive disease should be counseled to complete childbearing while renal function is preserved 8. Mild renal disease (creatinine <1.4 mg/dL) has minimal effect on fetal survival and typically does not worsen permanently 8.

References

Research

Acute Kidney Injury in Pregnancy.

Advances in chronic kidney disease, 2020

Research

Acute kidney injury in pregnancy including renal disease diagnosed in pregnancy.

Best practice & research. Clinical obstetrics & gynaecology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.